MARKET

LRMR

LRMR

Larimar Therapeutics Inc
NASDAQ
2.080
-0.040
-1.89%
After Hours: 2.080 0 0.00% 16:05 05/12 EDT
OPEN
2.120
PREV CLOSE
2.120
HIGH
2.280
LOW
2.070
VOLUME
1.30M
TURNOVER
--
52 WEEK HIGH
11.20
52 WEEK LOW
1.610
MARKET CAP
133.18M
P/E (TTM)
-1.3948
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LRMR last week (0505-0509)?
Weekly Report · 11h ago
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), PTC Therapeutics (PTCT) and Larimar Therapeutics (LRMR)
TipRanks · 05/05 17:50
Weekly Report: what happened at LRMR last week (0428-0502)?
Weekly Report · 05/05 12:01
Larimar Therapeutics (LRMR) Gets a Buy from Citi
TipRanks · 05/05 10:58
Larimar Therapeutics Advances Nomlabofusp Amid Financial Loss
TipRanks · 05/05 03:52
Biotech Alert: Searches spiking for these stocks today
TipRanks · 05/02 15:45
Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Humana (HUM) and Larimar Therapeutics (LRMR)
TipRanks · 05/01 12:02
Optimistic Buy Rating for Larimar Therapeutics Amid Promising Phase II Study and Regulatory Progress
TipRanks · 04/30 21:35
More
About LRMR
More
Larimar Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide (CPP) technology platform. The Company’s lead product candidate, nomlabofusp, is a subcutaneously administered, recombinant fusion protein intended to deliver tissue frataxin (FXN), an essential protein, to the mitochondria of patients with Friedreich's ataxia (FA). FA is a rare, progressive, and fatal disease in which patients are unable to produce sufficient FXN due to a genetic abnormality. Its CPP platform, which enables a therapeutic molecule to cross a cell membrane in order to reach intracellular targets, has the potential to enable the treatment of other rare and orphan diseases. The Company intends to use its proprietary platform to target additional orphan indications characterized by deficiencies in or alterations of intracellular content or activity.
Recently
Symbol
Price
%Change

Webull offers Larimar Therapeutics Inc stock information, including NASDAQ: LRMR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LRMR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LRMR stock methods without spending real money on the virtual paper trading platform.